amcure GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Amcure GmbH (Amcure) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of cancer. The company develops peptide-based compounds for the treatment of metastatic forms of cancer. Its lead candidate, AMC303 is used for the treatment of metastatic epithelial tumors such as colorectal, breast, lung, pancreatic, head and neck; and gastric cancers. Its AMC303 inhibits the growth of CD44v6, a co-receptor used for signaling through multiple cellular pathways that are involved in promoting tumor growth, angiogenesis and the development of metastases. The company operates through partnerships and grants with education and research organizations. Amcure is headquartered in Eggenstein-Leopoldshafen, Germany.

amcure GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
amcure GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
amcure GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
amcure GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
amcure GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
amcure GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
amcure GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
amcure Raises USD6.4 Million in Series B Financing 10
amcure Raises USD6.8 Million in Series A Financing Round 12
Equity Offering 13
amcure Spin-Off from from Karlsruhe Institute of Technology 13
amcure GmbH - Key Competitors 14
amcure GmbH - Key Employees 15
amcure GmbH - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
08/23/2017: amcure Announces Formation of Inaugural Scientific Advisory Board 17
01/15/2018: amcure Appoints Biotech Executive Heinz Schwer to its Board 18
Clinical Trials 19
Apr 17, 2018: amcure Presents Pre-Clinical Anti-tumor and Anti-Metastatic Effects of AMC303 at AACR 19
Sep 11, 2017: amcure Presents Phase I/Ib Study Design for Lead Compound AMC303 at ESMO 2017 Congress 20
Aug 31, 2017: amcure Receives Additional 1.75M BMBF Research Grant 21
Apr 04, 2017: Amcure Presents Preclinical Data on Lead Cancer Compound AMC303 at AACR Annual Meeting 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables


amcure GmbH, Pharmaceuticals & Healthcare, Key Facts 2
amcure GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
amcure GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
amcure GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
amcure GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
amcure GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
amcure Raises USD6.4 Million in Series B Financing 10
amcure Raises USD6.8 Million in Series A Financing Round 12
amcure Spin-Off from from Karlsruhe Institute of Technology 13
amcure GmbH, Key Competitors 14
amcure GmbH, Key Employees 15

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

amcure GmbH - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Amcure GmbH (Amcure) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of cancer. The company develops peptide-based compounds for the treatment of metastatic forms of cancer.

USD 250 View Report

amcure GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Amcure GmbH (Amcure) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of cancer. The company develops peptide-based compounds for the treatment of metastatic forms of cancer.

USD 250 View Report

Gilupi GmbH - Product Pipeline Analysis, 2019 Update

Gilupi GmbH (Gilupi) is a medical device company that develops and manufactures devices for the in vivo isolation of rare cells from the circulation. The company develops medical detector that

USD 750 View Report

Oettinger Brauerei GmbH - Strategy, SWOT and Corporate Finance Report

Oettinger Brauerei GmbH - Strategy, SWOT and Corporate Finance ReportOettinger Brauerei GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available